Back to Search
Start Over
Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential
- Source :
- Molecular pharmaceutics. 4(3)
- Publication Year :
- 2007
-
Abstract
- The cocrystal of celecoxib and nicotinamide (Cel:Nic) was crystallized from chloroform in a 1:1 ratio, and the structure has been solved from powder X-ray diffraction data. The dissolution and solubility of Cel:Nic are medium dependent and can be attributed to differences in conversion of Cel:Nic to celecoxib polymorphs I and III (Cel-I and Cel-III). The presence of low concentrations of surfactants facilitates the rapid conversion of neat Cel:Nic to large aggregates of Cel-III that dissolve more slowly than commercial Cel-III into 1% SDS solution. In contrast, combinations of Cel:Nic with both 1-10% solid SDS and PVP wet rapidly and convert to a mixture of amorphous celecoxib and a micron-sized crystalline celecoxib form IV (Cel-IV), which has recently been shown to be up to 4-fold more bioavailable than marketed Cel-III. More than 90% of the suspended material dissolves within 2 min at 37 degrees C when transferred to 1% SDS solution. This example highlights the importance of exploring the form conversion of cocrystals in aqueous media prior to pharmacokinetic studies, and illustrates the potential of simple formulations to overcome the limitations caused by rapid dissociation of cocrystals and recrystallization of poorly soluble forms in aqueous media.
- Subjects :
- Models, Molecular
Niacinamide
Magnetic Resonance Spectroscopy
Chemistry, Pharmaceutical
Pharmaceutical Science
Cocrystal
Dissociation (chemistry)
law.invention
Excipients
chemistry.chemical_compound
Surface-Active Agents
Drug Stability
law
Drug Discovery
Spectroscopy, Fourier Transform Infrared
Solubility
Crystallization
Dissolution
Sulfonamides
Chloroform
Nicotinamide
Molecular Structure
Nuclear magnetic resonance spectroscopy
Crystallography
chemistry
Celecoxib
Molecular Medicine
Pyrazoles
Powder Diffraction
Nuclear chemistry
Subjects
Details
- ISSN :
- 15438384
- Volume :
- 4
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Molecular pharmaceutics
- Accession number :
- edsair.doi.dedup.....3342f7d0c775f1a83fef0839792d63e7